We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$15.8B
AUM Growth
+$2.12B
Cap. Flow
+$1.31B
Cap. Flow %
8.29%
Top 10 Hldgs %
13.54%
Holding
1,739
New
469
Increased
384
Reduced
350
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 19.65%
2 Technology 16.89%
3 Consumer Discretionary 13.55%
4 Industrials 12.67%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
X
126
DELISTED
US Steel
X
$32.8M 0.21%
1,259,883
+268,742
+27% +$6.58M
DRI icon
127
Darden Restaurants
DRI
$23.9B
$32.6M 0.21%
+413,177
New +$34.8M
SYNH
128
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$32.1M 0.2%
617,138
-1,773
-0.3% -$98.9K
CMCSA icon
129
Comcast
CMCSA
$87.2B
$32.1M 0.2%
843,567
+185,076
+28% +$7.29M
PBR.A icon
130
Petrobras Class A
PBR.A
$106B
$32M 0.2%
3,202,617
+2,246,298
+235% +$19.6M
BRKR icon
131
Bruker
BRKR
$7.89B
$32M 0.2%
1,067,085
-363,048
-25% -$10.5M
NOMD icon
132
Nomad Foods
NOMD
$1.65B
$31.9M 0.2%
2,126,824
+1,753,963
+470% +$25.6M
MAS icon
133
Masco
MAS
$15.3B
$31.7M 0.2%
813,183
-1,357,670
-63% -$51.2M
EVHC
134
DELISTED
Envision Healthcare Holdings Inc
EVHC
$31.6M 0.2%
702,302
+688,529
+4,999% +$36.7M
PBR icon
135
Petrobras
PBR
$119B
$31.6M 0.2%
3,159,285
+1,322,814
+72% +$12M
VR
136
DELISTED
Validus Hold Ltd
VR
$31.6M 0.2%
+643,876
New +$32.7M
PTEN icon
137
Patterson-UTI
PTEN
$3.72B
$31.5M 0.2%
1,501,878
+374,434
+33% +$6.9M
CHTR icon
138
Charter Communications
CHTR
$18B
$31.1M 0.2%
85,758
-111,235
-56% -$41.4M
LRCX icon
139
Lam Research
LRCX
$390B
$31M 0.2%
+1,677,090
New +$27.2M
CERN
140
DELISTED
Cerner Corp
CERN
$30.9M 0.2%
+435,384
New +$28.9M
GPK icon
141
Graphic Packaging
GPK
$3.52B
$30.9M 0.2%
2,205,476
-1,641,231
-43% -$22M
CAG icon
142
Conagra Brands
CAG
$7.15B
$30.7M 0.19%
902,773
+632,687
+234% +$21.5M
ALK icon
143
Alaska Air
ALK
$5.81B
$30.5M 0.19%
400,811
+275,824
+221% +$22.6M
EXPE icon
144
Expedia Group
EXPE
$38B
$30.4M 0.19%
211,399
+199,678
+1,704% +$29.6M
PNR icon
145
Pentair
PNR
$11B
$30M 0.19%
656,784
+605,512
+1,181% +$26M
CLVS
146
DELISTED
Clovis Oncology, Inc.
CLVS
$30M 0.19%
365,420
+243,466
+200% +$19.3M
BLUE
147
DELISTED
bluebird bio
BLUE
$29.5M 0.19%
16,615
-10,278
-38% -$14.4M
EHC icon
148
Encompass Health
EHC
$11B
$29.1M 0.18%
795,528
+90,894
+13% +$3.24M
HPP
149
Hudson Pacific Properties
HPP
$823M
$29.1M 0.18%
122,211
+83,249
+214% +$19M
COHR
150
DELISTED
Coherent Inc
COHR
$28.7M 0.18%
122,035
+110,686
+975% +$26.7M

Similar funds

Marshall Wace North America's Q3 2017 Portfolio in Review

As of Q3 2017, Marshall Wace North America held 1,739 positions worth $15.8B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.31B of net new capital in Q3 2017, opening 469 new positions and adding to 384 existing holdings. Its largest new stake was Delta Air Lines: 1,523,510 shares worth $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Terminix Global Holdings, Inc., an estimated $113M trimmed.

  • Marshall Wace North America's largest Q3 2017 buy was Delta Air Lines: 1,523,510 shares worth $73.1M.
  • Marshall Wace North America added most to Johnson & Johnson in Q3 2017, an estimated $260M increase.
  • Marshall Wace North America's biggest Q3 2017 reduction was Terminix Global Holdings, Inc., cutting an estimated $113M.
  • Marshall Wace North America fully exited Reynolds American Inc in Q3 2017, selling an estimated $130M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $15.8B portfolio in Q3 2017.
  • Marshall Wace North America opened 469 new positions and closed 529 in Q3 2017.
  • Marshall Wace North America's portfolio value rose 16% quarter-over-quarter to $15.8B.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.